232 related articles for article (PubMed ID: 21656127)
21. HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene.
Aiello A; Pandini G; Sarfstein R; Werner H; Manfioletti G; Vigneri R; Belfiore A
Eur J Cancer; 2010 Jul; 46(10):1919-26. PubMed ID: 20335021
[TBL] [Abstract][Full Text] [Related]
22. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
23. The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.
Mussnich P; D'Angelo D; Leone V; Croce CM; Fusco A
Mol Oncol; 2013 Jun; 7(3):531-42. PubMed ID: 23384558
[TBL] [Abstract][Full Text] [Related]
24. MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1.
Chen CY; Chang JT; Ho YF; Shyu AB
Nucleic Acids Res; 2016 May; 44(8):3772-87. PubMed ID: 27025651
[TBL] [Abstract][Full Text] [Related]
25. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
[TBL] [Abstract][Full Text] [Related]
26. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
27. Regulatory Axis of miR-195/497 and HMGA1-Id3 Governs Muscle Cell Proliferation and Differentiation.
Qiu H; Zhong J; Luo L; Tang Z; Liu N; Kang K; Li L; Gou D
Int J Biol Sci; 2017; 13(2):157-166. PubMed ID: 28255268
[TBL] [Abstract][Full Text] [Related]
28. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.
Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M
Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4.
Chen T; Gao F; Feng S; Yang T; Chen M
Oncol Rep; 2015 Jul; 34(1):461-8. PubMed ID: 25976502
[TBL] [Abstract][Full Text] [Related]
30. miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells.
Liang WL; Cao J; Xu B; Yang P; Shen F; Sun Z; Li WL; Wang Q; Liu F
Biomed Pharmacother; 2015 May; 72():119-24. PubMed ID: 26054685
[TBL] [Abstract][Full Text] [Related]
31. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS; Rocha F; Matros E; Redston M; Whang E
Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
[TBL] [Abstract][Full Text] [Related]
32. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
33. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
[TBL] [Abstract][Full Text] [Related]
34. The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer.
Jeon SH; Yoo JK; Kim CM; Lim ES; Lee SJ; Lee JM; Oh SH; Kim JK
Cell Death Dis; 2018 May; 9(5):493. PubMed ID: 29712908
[TBL] [Abstract][Full Text] [Related]
35. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
36. miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.
Shi X; Zhan L; Xiao C; Lei Z; Yang H; Wang L; Zhao J; Zhang HT
Oncotarget; 2015 Aug; 6(22):19043-54. PubMed ID: 26189214
[TBL] [Abstract][Full Text] [Related]
37. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer.
Li D; Yang Y; Zhu G; Liu X; Zhao M; Li X; Yang Q
FEBS Lett; 2015 Aug; 589(17):2218-23. PubMed ID: 26149213
[TBL] [Abstract][Full Text] [Related]
40. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
